Nations Financial Group
UTHR icon

Nations Financial Group’s United Therapeutics UTHR Stock Holding History

Nations Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.28M Buy
4,216
+29
+0.7% +$15K 0.11% 192
2026
Q2 		$2.27M Buy
4,187
+71
+2% +$40K 0.11% 208
2026
Q1 		$2.44M Buy
4,116
+72
+2% +$35.9K 0.13% 189
2025
Q4 		$1.97M Buy
4,044
+524
+15% +$244K 0.1% 210
2025
Q3 		$1.48M Buy
3,520
+509
+17% +$171K 0.09% 237
2025
Q2 		$865K Buy
3,011
+77
+3% +$23K 0.06% 320
2025
Q1 		$904K Buy
2,934
+11
+0.4% +$3.77K 0.07% 294
2024
Q4 		$1.03M Buy
2,923
+19
+0.7% +$6.98K 0.08% 266
2024
Q3 		$1.04M Buy
2,904
+136
+5% +$45.9K 0.08% 271
2024
Q2 		$882K Buy
2,768
+1,329
+92% +$352K 0.07% 284
2024
Q1 		$331K Buy
1,439
+398
+38% +$89.8K 0.03% 513
2023
Q4 		$229K Buy
+1,041
New +$240K 0.02% 569

Other funds holding UTHR

Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return

Nations Financial Group's UTHR Position: Q3 2026 in Review

Nations Financial Group increased its United Therapeutics (UTHR) stake by 0.69% in Q3 2026, buying an estimated $15K and bringing the position to 4,216 shares worth $2.28M. The position accounts for 0.11% of the portfolio, ranked #192.

Nations Financial Group first reported a position in UTHR in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.44M in Q1 2026. 390 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Nations Financial Group held 4,216 shares of United Therapeutics worth $2.28M as of Q3 2026.
  • Nations Financial Group bought 29 United Therapeutics shares in Q3 2026, an estimated $15K.
  • United Therapeutics made up 0.11% of Nations Financial Group's portfolio in Q3 2026, its #192 holding.
  • Nations Financial Group first reported a position in United Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • Nations Financial Group's United Therapeutics position peaked at $2.44M in Q1 2026.
  • 390 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Nations Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.